Higin Capital

Asia, Kumamoto, Japan, Kumamoto

Description

Higin Capital is a venture capital firm.

Investor Profile

Higin Capital has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series Unknown, Series A, Series C rounds (top funding stages).
Majority of deals are located in Japan.
Strong thematic focus on Biotechnology, Health Care, Recruiting.

Stage Focus

Series Unknown (40%)
Series A (20%)
Series C (20%)
Series B (20%)

Country Focus

Japan (100%)

Industry Focus

Biotechnology
Health Care
Recruiting
Therapeutics
Artificial Intelligence (Ai)
Information Technology
Robotics
Software
Medical
Medical Device

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Higin Capital frequently co-invest with?

Sagin Capital & Consulting

Sagin Capital & Consulting

Asia, Saga, Japan, Saga

Co-Investments: 2

ANRI

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

QB Capital

Asia, Fukuoka, Japan, Fukuoka

Co-Investments: 1

Colopl Next

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

UntroD Capital

Asia, Tokyo, Japan, Sumida

Co-Investments: 1

Prologis Ventures

Prologis Ventures

North America, California, United States, San Francisco

Co-Investments: 1

Kintetsu Venture Partners

Kintetsu Venture Partners

Asia, Osaka, Japan, Osaka

Co-Investments: 1

mixi

Asia, Tokyo, Japan, Tokyo

Co-Investments: 1

DBJ Capital

Asia, Tokyo, Japan, Otemachi

Co-Investments: 1

global bridge Japan

global bridge Japan

Asia, Tokyo, Japan, Sumida

Co-Investments: 1

What are some of recent deals done by Higin Capital?

Kagoshima, Kagoshima, Japan

Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products.

ConsultingPharmaceuticalProduct ResearchVeterinary

Series BNov 11, 2025

Amount Raised: $9,747,064

Nishiku, Fukuoka, Japan

KAICO is a biotechnology company that provides hard-expressing proteins to develop drugs with a silkworm-baculovirus expression system.

Alternative MedicineBiotechnologyPharmaceuticalProduct Research

Series BApr 15, 2025

Amount Raised: $3,765,766

Minamata, Kumamoto, Japan

AMI specializes in the manufactuing, rental service, and sales of medical devices.

Health CareMedicalMedical Device

Series CDec 12, 2024

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics

Series AJun 5, 2023

Amount Raised: $9,109,510

Tokyo, Tokyo, Japan

Timee is Japan's leading gig working platform.

Recruiting

Series UnknownSep 14, 2020

Amount Raised: $12,673,672

Tokyo, Tokyo, Japan

Kokopelli is an Artificial Intelligence (AI) technology company that focuses on financial products and services.

Artificial Intelligence (AI)Information TechnologyRoboticsSoftware

Series UnknownApr 30, 2020

Amount Raised: $3,728,422

Find More Investors Like Higin Capital

Discover similar investors in our database and build your perfect investor list.

series_a Investors Investors in Kumamoto Browse All Investors Top Investors

Need help with your fundraising strategy?Read our fundraising guides